Stonepine Capital Management, LLC - ATYR PHARMA INC ownership

ATYR PHARMA INC's ticker is LIFE and the CUSIP is 002120202. A total of 38 filers reported holding ATYR PHARMA INC in Q2 2022. The put-call ratio across all filers is 10.13 and the average weighting 0.1%.

Quarter-by-quarter ownership
Stonepine Capital Management, LLC ownership history of ATYR PHARMA INC
ValueSharesWeighting
Q3 2023$7,310,066
-26.9%
4,626,624
-0.0%
2.43%
-32.6%
Q2 2023$9,994,804
-1.4%
4,627,224
-4.1%
3.60%
+6.1%
Q1 2023$10,134,016
+462.1%
4,825,722
+703.0%
3.40%
+319.1%
Q3 2022$1,803,000
+5.9%
600,980
-0.1%
0.81%
+2.4%
Q2 2022$1,702,000
-47.1%
601,5800.0%0.79%
-40.7%
Q1 2022$3,218,000
-18.0%
601,580
+14.5%
1.34%
-25.9%
Q4 2021$3,926,000
+5.3%
525,531
+28.0%
1.80%
+6.2%
Q3 2021$3,728,000410,5351.70%
Other shareholders
ATYR PHARMA INC shareholders Q2 2022
NameSharesValueWeighting ↓
Tikvah Management LLC 1,225,833$9,157,0002.55%
Stonepine Capital Management, LLC 525,531$3,926,0001.80%
Telemetry Investments, L.L.C. 176,782$1,321,0001.70%
TANG CAPITAL MANAGEMENT LLC 1,113,453$8,317,0001.67%
VR Adviser, LLC 1,565,000$11,691,0001.60%
Deep Track Capital, LP 1,100,000$8,217,0000.58%
EAM Investors, LLC 252,280$1,885,0000.31%
EAM Global Investors LLC 152,792$1,141,0000.20%
FEDERATED HERMES, INC. 5,222,250$39,010,0000.07%
Alyeska Investment Group, L.P. 674,975$5,042,0000.06%
View complete list of ATYR PHARMA INC shareholders